SRTS — Sensus Healthcare, Inc.

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1494891 ·
Last close
$2.74
Market Cap
$45.11M
52W High
$4.55
52W Low
$2.66
ADV30
58,800
Next earnings
2026-08-06
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 +; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos, as well as provide operational healthcare services for dermatology clinics. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. The company was incorporated in 2010 and is based in Boca Raton, Florida.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 3,394,000 991,000 -4,358,000 -2,626,000 51,546,000 18,327,000 6,004,000
Dec 2025 4,939,000 1,897,000 -3,148,000 -3,167,000 53,039,000 22,083,000 4,941,000
Sep 2025 6,884,000 2,713,000 -2,569,000 -943,000 58,295,000 24,453,000 7,101,000
Jun 2025 7,315,000 2,903,000 -1,943,000 -1,037,000 58,852,000 22,162,000 6,788,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-548,000
Investing CF
$-192,000
Financing CF
$-5,000
CapEx
$-192,000
Dividends Paid
Buybacks
$0
EPS Diluted TTM
$-0.47
As of
2026-06-07

Balance + Analyst (yfinance extras)

Retained Earnings
$3,089,000
Inventory
$16,500,000
Receivables
$3,578,000
ST Investments
EBIT TTM
$-12,018,000
Pretax Income TTM
$-11,395,000
Interest Exp TTM
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$22,532,000
EBITDA
$-11,622,500
Free Cash Flow
$3,935,125
Enterprise Value
$27,186,042
Total Cash
$18,327,000
Total Debt
$407,000
Shares Out
16,462,059
Trailing EPS
$-0.47
Book Value
$2.92
ROE
-15.8%
ROA
-13.4%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 27,482,000 -10,307,000 -7,719,000 53,039,000 4,941,000 528,000
Dec 2024 41,807,000 8,090,000 6,647,000 62,165,000 6,338,000 -831,000
Dec 2023 24,405,000 -382,000 485,000 53,710,000 4,868,000 -2,145,000
Dec 2022 44,532,000 14,831,000 24,244,000 56,735,000 8,666,000 -1,412,000

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$-0.02

Max Pain — expiry 2026-07-17 (volume-derived — Yahoo OI feed degraded)

max pain strike: $2.00 · spot: $2.93 · call volume: 14 · put volume: 0

Peers — same industry

TickerNameMarket CapLastDaily %
IDXG INTERPACE BIOSCIENCES, INC. $45.15M $1.63
MYO MYOMO, INC. $45.98M $1.19
DRIO DarioHealth Corp. $43.80M $5.99
AURX Nuo Therapeutics, Inc. $43.80M $0.90
STSS SkyAI, Inc. $49.94M $1.18

News headlines (Yahoo Finance, 1h cache)

How The Sensus Healthcare (SRTS) Story Is Shifting With New Targets And 2026 Reimbursement Changes
2026-05-20 14:13 · Yahoo
Sensus Healthcare Q1 Earnings Call Highlights
2026-05-09 02:05 · Yahoo
Sensus Healthcare Announces Amicable Resolution of Commercial Dispute with SkinCure Oncology
2026-05-08 15:18 · Yahoo
Sensus (SRTS) Q1 2026 Earnings Transcript
2026-05-07 22:50 · Yahoo
Sensus Healthcare Reports First Quarter 2026 Financial Results and Business Highlights
2026-05-07 20:05 · Yahoo
Pleasing Signs As A Number Of Insiders Buy Sensus Healthcare Stock
2026-05-06 11:58 · Yahoo
Sensus Healthcare to Report First Quarter 2026 Financial Results and Hold Business Update Conference Call on May 7, 2026
2026-04-23 21:56 · Yahoo
2 Reasons Why Wells Fargo Thinks You Should Buy Google Stock Now
2026-03-31 11:30 · Yahoo
Sensus Healthcare Files Lawsuit Against SkinCure Oncology for Breach of Contract
2026-03-27 12:00 · Yahoo
Why The Sensus Healthcare (SRTS) Story Is Shifting As Targets Diverge On 2026 Expectations
2026-03-11 16:12 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.